Pasithea Therapeutics Corp. ( KTTA) - Stock Earnings
KTTA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.0 million USD | — USD |
| 2025Q4 | -10.1 million USD | — USD |
| 2026Q1 | -2.9 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
KTTA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.0 million USD | 486559 USD |
| 2024 | -13.9 million USD | — USD |
| 2025 | -20.4 million USD | — USD |
| 2026 Est. | — | — |
KTTA
Price: $0.50
52 week price:
Earnings Per Share: -1.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 51500
Market Capitalization: 19.5 million